This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Johns Hopkins University. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bronx, NY (US) (2015)
- North Potomac, MD (US) (2011 - 2016)
- Potomac, MD (US) (2016)
Company Filing History:
6 out of 3,696 
2 out of 3,801 
Years Active: 2011-2016
Title: The Innovative Contributions of Steven K. Libutti
Introduction
Steven K. Libutti is a prominent inventor based in North Potomac, MD (US). He has made significant contributions to the field of medical science, particularly in cancer research and treatment. With a total of 6 patents to his name, Libutti's work has the potential to impact the diagnosis and treatment of various cancers.
Latest Patents
Among his latest patents, Libutti has developed a method involving FILIP1L nucleic acid fragments. This invention provides a purified DOC1 polypeptide comprising a fragment of SEQ ID NO:1, which is not the full-length DOC1 polypeptide sequence. The method aims to inhibit angiogenesis in a subject by administering a nucleic acid encoding a DOC1 polypeptide, allowing a cell in the subject to produce the DOC1 polypeptide and thus inhibit angiogenesis. Additionally, he has created a method for inhibiting tumor growth in a subject through a similar approach. Another notable invention is a diagnostic tool for differentiating between benign and malignant thyroid lesions. This tool utilizes genes that are differentially expressed in these lesions for the diagnosis and staging of thyroid cancer.
Career Highlights
Libutti has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Johns Hopkins University. His work in these institutions has furthered the understanding and treatment of cancer.
Collaborations
Throughout his career, Libutti has collaborated with notable colleagues, including Martha Allen Zeiger and Christopher Umbricht. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Steven K. Libutti's innovative contributions to cancer research and treatment exemplify the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in cancer diagnosis and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile